焦虑
大流行
2019年冠状病毒病(COVID-19)
精神科
心理健康
跨国公司
2019-20冠状病毒爆发
萧条(经济学)
药品
医学
心理学
病毒学
政治学
疾病
病理
法学
爆发
传染病(医学专业)
经济
宏观经济学
作者
Hao Luo,Yi Chai,Sijia Li,Wallis C. Y. Lau,Carmen Olga Torre,Joseph Hayes,Ivan Chun Hang Lam,Xiaoyu Lin,Can Yin,Stephen Fortin,Dave M Kern,Dong Yun Lee,Rae Woong Park,Jae‐Won Jang,Celine Sze Ling Chui,Jing Li,Sarah Seager,Kenneth K. C. Man,Ian C. K. Wong
标识
DOI:10.1016/s2215-0366(24)00245-1
摘要
People with mental health conditions were potentially more vulnerable than others to the neuropsychiatric effects of the COVID-19 pandemic and the global efforts taken to contain it. The aim of this multinational study was to examine the changes in psychotropic drug prescribing during the pandemic among people with depressive and anxiety disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI